|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Provision for credit losses | |||||
| Depreciation of premises and equipment | |||||
| Accretion of building grant | |||||
| Net amortization (accretion) of purchase accounting adjustments | |||||
| Net amortization (accretion) of securities | |||||
| Net realized loss on sale of securities | |||||
| Proceeds from sale of loans in secondary market | |||||
| Loans disbursed for sale in secondary market | |||||
| Amortization of mortgage servicing rights | |||||
| Gain on sale of loans | |||||
| Accretion of purchased loan discount | |||||
| Amortization of intangible assets | |||||
| Deferred tax (benefit) expense | |||||
| Contribution of common stock to ESOP | |||||
| Income from bank owned life insurance and annuity assets | |||||
| Change in accrued interest receivable | |||||
| Change in other liabilities | |||||
| Change in other assets | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Proceeds from sales of securities available for sale | |||||
| Proceeds from maturities and paydowns of securities available for sale | |||||
| Purchases of securities available for sale | |||||
| Proceeds from calls and maturities of securities held to maturity | |||||
| Proceeds from maturities of certificates of deposit in financial institutions | |||||
| Purchases of certificates of deposit in financial institutions | |||||
| Purchases of restricted investments in bank stocks | |||||
| Redemptions of restricted investments in bank stocks | |||||
| Net change in loans | |||||
| Purchases of premises and equipment | |||||
| Disposals of premises and equipment | |||||
| Proceeds from building grant | |||||
| Reimbursement of building grant | |||||
| Purchases of bank owned life insurance and annuity assets | |||||
| Withdrawals from bank owned life insurance and annuity assets | |||||
| Net cash (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Change in deposits | |||||
| Cash dividends | |||||
| Purchases of treasury stock | |||||
| Proceeds from Federal Home Loan Bank borrowings | |||||
| Repayment of Federal Home Loan Bank borrowings | |||||
| Change in other short-term borrowings | |||||
| Net cash provided by financing activities | |||||
| Cash and cash equivalents: | |||||
| Change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental disclosure: | |||||
| Cash paid for interest | |||||
| Transfers from loans to other real estate owned | |||||
| Cash paid for income taxes | |||||
| Operating lease liability arising from obtaining right-of-use asset | |||||
Loading...
